Editorial: New advances in Candida infections: pathogenesis, diagnosis, and treatment

of deep fungal and to evaluate factors with mortality among inpatients in a 31 hospital in southwestern China. total of 462 deep infection cases were identified (0.052% of hospitalizations) from 2020 to 2024. Candida remained the predominant pathogen (84.2%), 33 while Aspergillus (13.9%) and Cryptococcus (6.71%) showed rising prevalence. The respiratory tract 34 was the primary site of infection (88.6%). Most patients received azole therapy, although echinocandin 35 treatment was associated with significantly higher survival rates. Key risk factors for poor prognosis 36 include mixed infections, hematologic diseases, and the use of biological agents. Overall, the study 37